Effect of vaccination and the immunomodulators 'bacillus of Calmette-Guerin, Avridine and Propionibacterium acnes' on rabies in mice

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 21, Issue 4, 1998, Pages 305-318

  Megid, J ^a   Peracolli M T S ^a   Curi, P R ^a   Zanetti, C R ^b   Cabrera, W H ^c   Vassao, R ^c   Ito, F H ^d  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Instituto Pasteur de Sao Paulo   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

INTERFERON; Cellular immunity; Humoral immunity; Immunomodulators; Mice; MIF; Rabies

Indexed keywords

AVRIDINE; BCG VACCINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PROPIONIBACTERIUM ACNES; RABIES; SURVIVAL RATE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; DIAMINES; FEMALE; INTERFERON TYPE II; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; NEUTRALIZATION TESTS; PROPIONIBACTERIUM ACNES; RABIES; RABIES VACCINES; VACCINATION;

ANIMALIA; CORYNEBACTERIUM; MYCOBACTERIUM BOVIS BCG; PROPIONIBACTERIUM ACNES;

EID: 0344404267     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(98)00005-8     Document Type: Article

References (51)

1. Al-Izzi S.A., Maxie M.G. Effect of Corynebacterium parvum on bone marrow macrophage colony production, peripheral blood leucocytes, and histologic changes of tissues in calves. Am J Vet Res. 43:1982;2244-2247.
2. Archambault D., Morin G., Elazhary M.A.S.Y. Effect of sodium diethyldithiocarbamate, Corynebacterium parvum and mycobacterium cell wall extract on in vitro blastogenic responses of bovine blood lymphocytes. Cornell Vet. 79:1989;11-24.
3. Baer G.M., Yager P.A. A mouse model for post-exposure rabies prophylaxis: the comparative efficacy of two vaccines and of antiserum administration. J Gen Virol. 36:1977;51-58.
4. Baer G.M. Animal models in the pathogenesis and treatment of rabies. Rev Infect Dis. 10 (Suppl. 4):1988;739-750.
5. Barakat A.A., Saber M.S., Emad N., Abdel-Ghaffar S., El-Nimr M.M.H., Sobhy K., Fathia M., Mohsen A.Y.A., El-Nakashly S. Preliminary studies on the use of BCG as an immunopotentiating agent against Rift Valley Fever among sheep in Egypt. Bull l'Office Int Epizooties. 93:1981;1387-1393.
6. Blancou J., Andral L., Lagrange P.H., Tsiang H. Kinetics of different specific immunological parameters after rabies vaccination in mice. Infect Immun. 24:1979;600-605.
7. Bomford R. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. 1. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol. 39:1980;426-434.
8. Bussereau F., Picard M., Malick C., Tézé A., Blancou J. Efficacy of heteropolyanions against rabies virus infection in mice. Ann Inst Pasteur Virol. 137E:1986;391-400.
9. Campbell JB, Charlton KM. Rabies. London: Kluwer Academic, 1988. 431 p.
10. Celis E., Miller R.W., Wiktor T.J., Dietzschold B., Koprowski H. Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-γ J Immunol. 136:1986;692-697.
11. Chavali S.R., Campbell J.B. Immunomodulatory effects of orally-administered saponins and nonspecific resistance against rabies infection. Int Arch Allergy Appl Immunol. 84:1987;129-134.
12. Cherwinski H., Schumacher J., Browm K., Mosmann F. Two types of mouse helper cell clone. 3. Further differences in lymphokynes synthesis between tH1 and tH2 clones revelated by DNA hybridization functionally monospecific bioessay and monoclonal antibody. J Exp Med. 166:1987;1229-1244.
13. Cox W.I. Examining the immunologic and hematopoietic properties of an immunostimulant. Vet Med. 83:1988;424-428.
14. Defaveri J., Rezkallah-Iwasso M.T., Franco M.F. Experimental pulmonary paracoccidioidomycosis in mice: morphology and correlations of lesions with humoral and cellular immune responses. Mycopathology. 77:1982;3-11.
15. Desiderio JD, Rankin BM. Imunomoduladores. In: Atualização terapêutica veterinária, vol. 1. São Paulo, Manole, 1988, p. 1379-1385.
16. Fangtao L., Shubeng C., Yinzhon W., Chenzhe S., Fanzhen Z., Guanfu W. Use of serum and vaccine in combination for prophylaxis following exposure to rabies. Rev Infect Dis. 10 (Suppl. 4):1988;766-770.
17. Favoretto S.R., Carrieri M.L., Tino M.S., Zanetti C.R., Pereira O.A.C. Simplified fluorescence inhibition microtest for the titration of rabies neutralizing antibodies. Rev Inst Med Trop São Paulo. 35:1993;171-175.
18. Gerber J.D., Sharpee R.L., Swieczkowski T.C., Beckenhauer W.H. Cell-mediated immune response to rabies virus in dogs following vaccination and challenge. Vet Immunol Immunopathol. 9:1985;13-22.
19. Glasgow L.A., Fischbach J., Bryant S.M., Kern E.R. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille Calmett-Guérin. J Infect Dis. 135:1977;763-770.
20. Goldwasser R.A., Kissling R.E. Fluorescent antibody staining of street and fixed rabies virus antigens. Proc Soc Exp Biol New York. 98:1958;219-223.
21. Harmon M.W., Janis B. Therapy of murine rabies after exposure: efficacy of polyriboinosinic-polyribocytidylic acid alone and in combination with three rabies vaccines. J Infect Dis. 132:1975;241-249.
22. Ho M., Nash C., Morgan C.W., Armstrong J.A., Carrol R.G., Postic B. Interferon administered in the cerebrospinal space and its effect on rabies in rabbits. Infect Immun. 9:1974;286-293.
23. Kawano H., Mifune K., Ohuchi M., Mannen K., Cho S., Hiramatsu K., Shichijo A. Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus. J Gen Virol. 71:1990;281-287.
24. Koprowski H, Prueba de inoculacion al raton. In: Kaplan MM, Koprowski H, editors. La rabia, tecnicas de laboratorio. 3 ed. Ginebra. Organizacion Mundial de la Salud, 1976, cap. 7, p. 88-97.
25. Koprowski H. Visit to an ancient curse. Sci Am Sci Med 1995;48-57.
26. Lagrange P.H. Nonspecific resistance to virus infection induced by immunostimulation. Bull l'Inst Pasteur. 75:1977;291-307.
27. Lagrange P.H., Tsiang H., Hurtrel B., Ravisse P. Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test. Infect Immun. 21:1978;931-939.
28. Lichenstein A, Bick A, Cantrell J et al. Augmentation of NK activity by Corynebacterium parvum fractions in vivo and in vitro. Int J Immunopharmac 1982;58:257-62; apud Tizard I, 1991:1485.
29. Lichenstein A, Bick A, Cantrell J et al. Augmentation of NK activity by Corynebacterium parvum fractions in vivo and in vitro. Int J Immunopharmac 1982;58:257-62; apud Tizard I, 1991:1485.
30. Lin H.X., Gontier C., Saron M.F., Perrin P. A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects. Arch Virol. 131:1993;307-319.
31. Lopes CAC, Santana CF. Novas observações sobre o emprego do Corynebacterium parvum em pacientes portadores de doenças infecciosas. Pernambuco: Ministério da Educação e Cultura, Universidade Federal de Pernambuco, 1984. 15 p.
32. Macfarlan R.I., Dietzschold B., Koprowski Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain. Mol Immunol. 23:1986;733-741.
33. Marcovistz R., Galabru J., Tsiang H., Hovanessian A.G. Neutralization of interferon produced early during rabies virus infection in mice. J Gen Virol. 67:1986;387-390.
34. Mendonça R.Z., Pereira C.A. Relationship of interferon synthesis and the resistance of mice infected with street rabies virus. Braz J Med Biol Res. 27:1994;691-695.
35. Mifune K., Mannen K., Cho S., Narahara H. Enhanced antibody responses in mice by combined administration of interferon with rabies vaccine. Arch Virol. 94:1987;287-295.
36. Niblack J.F., Otterness I.G., Hemsworth G.R., Wolff J.S., Hoffman W.W., Kraska A.R. CP-20,961: A structurally novel, synthetic adjuvant. J Reticuloendothelial Soc. 26:1979;655-666.
37. Nunberg J.H., Doyle M.V., York S.M., York C.J. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc Natl Acad. Sci. USA. 86:1989;4240-4243.
38. Pepin M., Blancou J. Ammonium-5-Tungsto-2-Antimoniate (HPA23) can prevent fox rabies. Arch Virol. 83:1985;327-329.
39. Perrin P., Joffret M.L., Leclerc C., Oth D., Sureau P., Thibodeau L. Interleukin 2 increases protection against experimental rabies. Immunobiology. 177:1988;199-209.
40. Santana C.F., Asfora J.J., Lins L.P., Lopes C.A.C., Santos E.R. Efeitos imunoestimulantes do Corynebacterium parvum em pacientes portadores de neoplasias malígnas. Rev Inst Antibióticos UFPE. 19:1979;137.
41. Schijns V.E.C.J., Claassen I.J.T.M., Vermeulen A.A., Horzinek M.C., Osterhaus A.D.M.E. Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-α, interleukin-1α, interleukin-2 and interferon-γ on the immunogenicity of an inactivated rabies vaccine. J Gen Virol. 75:1994;55-63.
42. Smith J.S. Mouse model for abortive rabies infection of the central nervous system. Infect Immun. 31:1981;297-308.
43. Smith J.S., McClelland C.L., Reid F.L., Baer G.M. Dual role of the immune response in street rabiesvirus infection of mice. Infect Immun. 35:1982;213-221.
44. Sodja I. Experimental chemotherapy of rabies: Preliminary results. Acta Virol. 30:1986;63-68.
45. Spencer J.C., Ganguly R., Waldman R.H. Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guérin. J Infect Dis. 136:1977;171-175.
46. Tsiang H., Lagrange P.H. In vivo detection of specific cell-mediated immunity in street rabies virus infection in mice. J Gen Virol. 47:1980;183-191.
47. Tizard I. Use of immunomodulators as an aid to clinical management of feline leukemia virus-infected cats. J Am Vet Med Assoc. 199:1991;1482-1485.
48. Tizard I. Round-Table Discussion. Eqstim® Immunostimulant. 37 Annual AAEP Meeting, 1992. J Equine Vet Sci. 12:1992;209-214.
49. Weiss R.C., Cox N.R., Oostrom-Ram T. Effect of interferon or Propionibacterium acnes on the course of experimentally induce feline infectious peritonitis in specific-pathogen-free and random-source cats. Am J Vet Res. 51:1990;726-733.
50. Wiktor T.J., Postic B., Ho M., Koprowski H. Role of interferon induction in the protective activity of rabies vaccines. J Infect Dis. 126:1972;408-418.
51. Zar H, Biostatistical analysis. International Editions, 2 ed. Englewood Cliffs: Prentice-Hall, 1984. 718 p.